Cannabis Association With Sleep Study
CaSS
Longitudinal Reciprocal Relationships Between Cannabis Use, Sleep, and the HPA-axis (CaSS)
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The purpose of this study is to learn more about cannabis use, sleep, and stress, and whether there is any relationship between the three.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2025
CompletedFirst Posted
Study publicly available on registry
May 21, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2032
May 21, 2025
May 1, 2025
5 years
May 3, 2025
May 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Daily Cannabis Use Frequency
The number of smoking/vaping sessions per day.
Assessed in surveys performed 4 times per day, and across the entire 21-day study
Wake After Sleep Onset (WASO)
Wake after sleep onset (measured in minutes) will be assessed each night from actigraphy; larger value indicates greater disruptions to sleep.
21 days
Cortisol Awakening Response
Salivary cortisol levels assessed as the difference between waking and peak levels assessed \~30-45 minutes after awakening.
8 nights
Secondary Outcomes (18)
Wake After Sleep Onset (Polysomnography)
8 nights
Sleep Latency
8 nights
Total Sleep Time
up to 21 days
Sleep Macroarchitecture
8 nights
Sleep Microarchitecture
8 nights
- +13 more secondary outcomes
Study Arms (2)
Sleep Restriction
EXPERIMENTALAfter a baseline assessment of sleep, participants in this arm will undergo 2 nights of restricted sleep (4 hour time in bed).
Sleep Extension
EXPERIMENTALAfter a baseline assessment of sleep, participants in this arm will undergo 3 nights of an extended sleep opportunity (10 hour time in bed).
Interventions
After a baseline assessment of sleep, participants will undergo either 2 nights of restricted sleep (4 hour time in bed) followed by a recovery sleep, OR 3 nights of an extended sleep opportunity (10 hour time in bed)
Eligibility Criteria
You may qualify if:
- fluent in English
- \<BMI\<40 kg/m2
- no shift work in the last 12 months
- no travel across time zones in the last 2 months.
You may not qualify if:
- Chronic disease-Medical history/prior diagnosis of the following:
- cardiometabolic disease (e.g., myocardial infarction, angina, diabetes)
- essential hypertension
- hepatic impairment
- severe obstructive sleep apnea
- restless legs syndrome
- parasomnia
- neurological disease (e.g., early onset dementia)
- unstable psychiatric disorders (e.g., bipolar disorder, schizophrenia, major depression with suicidality).
- Drug/Alcohol use criteria:
- Illicit drugs apart from cannabis or related products are prohibitive.
- Volunteers may consume caffeine, however, \>3 cups of coffee (or otherwise equivalent of \>300mg/day) is prohibitive.
- Participants who consume \>14 alcoholic drinks/week and/or have a diagnosis (or history) of alcohol use disorder will be excluded (a toxicological urine screen will be conducted to verify reported non-use during the initial screening and on the day of admission to the in-laboratory portion of the study).
- Contraceptives are required for women and will continue to be taken throughout the experiment.
- Prior Shift Work:
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assitant Professor
Study Record Dates
First Submitted
May 3, 2025
First Posted
May 21, 2025
Study Start
July 1, 2025
Primary Completion (Estimated)
June 30, 2030
Study Completion (Estimated)
June 30, 2032
Last Updated
May 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share